W L Allen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W L Allen

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 23, 2020

Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacityJ W L Allen, H Verkerke, J Owens, et al.

Cell Death & Disease|February 8, 2014

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancerR C Turkington, D B Longley, W L Allen, et al.

JCO Precision Oncology|August 9, 2018

Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 23, 2020

Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacityJ W L Allen, H Verkerke, J Owens, et al.

Cell Death & Disease|February 8, 2014

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancerR C Turkington, D B Longley, W L Allen, et al.

JCO Precision Oncology|August 9, 2018

Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.

Pageof 3